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SUMMARY
As an extension of our first observation in which the periph-
eral blood lymphocytes of an aplastic amaemia patient with a
transplant were able to show HLA-restricted H-Y killing in a
cell-mediated lympholysis assay, we report here a second case
showing exactly the same phenomenon.
Α multitransfused woman suffering from aplastic anaemia
was shown to have in vitro killing after priming her lymphocytes
with her HLA-identical brother. This killing was directed to all
male target cells carrying the HLA-A2 antigen. Marginally,
killing was also directed to some HLA-A2 female target cells,
but this was at a considerably lower level than that directed to
male cells. The level of HLA-restricted H-Y killing declined
with time. However, it was possible to reactivate the H-Y
specific killing by in vitro Stimulation with lymphocytes from
an HLA-A, -B, and -C-identical, but HLA-D-different male
donor. That these findings could be relevant for renal trans-
plantation was supported by renal allograft survival data ob-
tained at 2 years after transplantation. Male allografts from
HLA-A2-positive donors in A2-positive females survived for a
significantly shorter time than non-A2 male kidneys in non-A2
female recipients. This was only apparent in recipients who
produced antileukocyte antibodies.
Observations in the mouse have shown that gene products
coded for on the Υ chromosome can play a role in graft rejection
(4). In various strains, skin grafts from males are rejected by
isologous females and it is possible to generate cytotoxic Τ cells
which specifically kill male cells (5, 15). We have recently
described the case of a woman who had been hyperimmunized
by pregnancies, blood transfusion, and a bone marrow graft
from an HLA-identical sibling donor (7). She had developed
effector cells against all male phytohaemagglutinin blasts that
were positive for HLA-A2, an antigen that she shared with her
brother who donated the bone marrow.
In this publication we show that, although with time the
level of killing declined almost to background, it could be
recalled by restimulation with HLA-A and -B-identical, but
HLA-D non-identical lymphocytes from an unrelated male
donor. Α second patient showing the same phenomenon is also
described. Furthermore, the possible relevance of this finding
for renal transplantation is discussed.
MATERIALS AND METHODS
The cell-mediated lympholysis (CML) assay used has been
previously described in detail (6). Briefly, cytotoxicity was
measured using an isotope release assay with target cells that
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had been incubated with phytohaemagglutinin for 3 days and
then labelled with 100 jiic of 51Cr(51Cr Na2 Cr O4, 5 mc/5 ml;
specific activity 100 to 350 mc/mg, Amersham CJS 1P) for 1 hr
at 37 C. The effector cells were collected from the tissue culture
flasks after 6 days in culture using 8 Χ 106 responder cells and
16 Χ 106 stimulator cells. Effector cells (70, 50, and 25 X 10")
and target cells (1 Χ 104) in RPMI-1640 medium plus 20% heat-
inactivated human AB serum were incubated for 4 hr in round-
bottomed microtiter plates. After incubation the plates were
centrifuged for 5 min at 200 g, and the supernatant was removed
and counted in a gamma counter. All combinations were tested
in triplicate. The Variation coefficient within the triplicates was
less than 10%.
The degree of chromium release of a target was found to vary
between target cells. Some cells gave very high spontaneous
release while others gave low spontaneous release. Because of
this, the degree of specific release could not simply be expressed
as an index of spontaneous release. It was further noted that a
linear relationship existed between the level of spontaneous
release and the level of maximum release on freeze-thawing
(Fig. 1). Thus the data were expressed on a scale on which 0%
was made equivalent to the spontaneous release value and 100%
was made equivalent to the freeze-thaw value. This was calcu-
lated for each target cell using the following formula:
experimental mean —
mean of spontaneous release
freeze-thaw mean (100% release)
— mean of spontaneous release
X 100% = % kill
Percentages lower than 10% were considered negative. All ex-
periments were repeated at least once.
Effector cells from two female patients are described in this
paper.
Patient 1. Mrs. R. had been suffering from a severe aplastic
anaemia. She had had four pregnancies, received more than 100
units of blood and blood products, and, after antithymocyte
globulin pretreatment, bone marrow from her HLA-identical
brother.
Patient 2. Mrs. K. suffered from aplastic anaemia. She had
had three pregnancies and received more than 20 units of blood
or blood products. She did not receive a transplant.
All individuals were typed for HLA-A, -B, and -C and in
some cases also for HLA-D locus products. The results of
cadaveric renal allograft survival were collected under the aus-
pices of the Eurotransplant Organization. No distinction was
made between first and second grafts and all were included in
the analysis.
RESULTS
Until now we have studied a group of 14 aplastic anaemia
patients including males and females and HLA-A2-positive and
-negative individuals. In five patients positive CML reactions
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were detected against HLA-identical target cells, and in three
of these killing was also detected against cells of HLA-identical
siblings. These latter three were female patients carrying HLA-
A2 and they were able to kill the cells of their HLA-identical
male siblings. Extensive segregation studies have now been
completed in two of these individuals, using families and panels
of unrelated individuals. They indicated that the target antigen
was coded for by the Υ chromosome and was a probable human
equivalent of the H-Y histocompatibility antigen in rodents.
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FIGURE 1. Relationship between spontaneous release and freeze-thaw
values.
Preliminary data also suggested that a similar phenomenon
occurred in a recently studied third patient.
H-Y-specific cytotoxicity. The pattern of killing obtained
with effector cells of patient 2 (Mrs. K.) after restimulating in
vitro against members of her family showed that the target
antigen was not a product of the HLA region per se (Table 1).
The patient had two HLA-identical siblings (sib), a sister (sib
1) and a brother (sib 2). When cells from sib 1 were used for
restimulating, they failed to generate cytotoxic cells but when
sib 2 cells were used cytotoxic cells were generated. They were
capable of killing target cells from both sib 2 and the father.
Furthermore, the cytotoxic cells generated when the father's
lymphocytes were used for restimulation were able to kill cells
from sib 2 but not from sib 1.
Despite this nonsegregation with the HLA haplotype when
panel studies were performed using a series of target cells
derived from unrelated individuals, an association with HLA
was found. Effector cells were made using patient 2 restimulated
to sib 2 and these were tested on the panel (Table 2). All male
HLA-A2-positive target cells gave a high percentage of killing
(32 to 53%), whereas non-A2 male cells gave zero killing (—1 to
—2%). Α variable degree of killing at a low level was shown by
HLA-A2-positive female target cells (-2 to 17%), but non-A2
female target cells gave zero killing (—3 to +1%).
Memory and recall of the phenomenon. Patient 1 was studied
on seven occasions between the 25th and the 74th week after
transplantation. Α consistent decline was found in the killing of
the HLA-identical brother's cells (Table 3). After 1% years the
level of kill was only slightly above background. Nevertheless,
it was possible to recall the H-Y-specific effector cells by an in
vitro Stimulation using lymphocytes from an HLA-A, -B, and
-C-identical but HLA-D-different donor (Table 4). Such effector
cells retained their specificity for HLA-A2 males as Seen in the
repeat panel study shown in Table 5.
Possible relevance in renal transplantation. Cadaveric renal
allograft survival data, collected under the auspices of Euro-
transplant, were examined 2 years after transplantation for the
influence of sex. It was found that a significant difference existed
between HLA-A2 females who received HLA-A2 male kidneys
and non-HLA-A2 females who received non-HLA-A2 male
kidneys (Table 6). This occurred only in those patients who
produced antibodies to leukocytes but not in the antibody-
negative group. The data are compatible with the assumption
that H-Y incompatibility in donor-recipient combinations that
TABLE 1. Killing pattern of cells from patient 2 (Mrs. K. against her family)
Responder X stimulator
(sensitizing haplotype)
Target cells" (haplotypes-sex)
Stimulation index in mixed
leukocyte culture
4,8
3,4
1,8
3,1
1,1
Father (ab)
12b
2
NT"
45
NT
Mother (cd)
5
1
NT
N T
NT
Patient (ac-fe-
male)
- 2
- 2
- 2
- 2
NT
Sib 1 (ae-female)
1
- 1
- 2
- 2
N T
Sib 2 (ac-male)
62
- 1
NT
45
NT
Patient X father (b)
Patient X mother (d)
Patient X sib 1 (-)
Patient X sib 2 (-)
Sib 2 x patient (-)
" HLA haplotypes:
a: 2 W15.2 W6 CW3
6: 9 W6
c: 3 W40 W6 CW3
d: 28 7 W6
b
 Figures represented percentage of Cr release; effector to target ratio = 70:1.
' NT, not tested.
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 TABLE 2. Killing of target cells from unrelated individuals by cells from
Targets
Patient 2
Brother
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
2"
2
2
1
2
2
1
3
—
1
2
2
2
2
2
2
2
2
2
1
11
1
1
HLA-A
3
3
3
2
3
^
W25
3
3
9
W32
3
3
3
3
3
11
3
9
—
28
W31
3
9
patient 2 (Mrs.
HLA phenotypes
HLA
W15.2
W15.2
W15.2
8
7
12
8
7
18
18
8
8
7
7
7
W17
7
W22
8
5
W15.2
8
8
Β
W40
W40
W40
W40
12
W40
27
W39
W17
27
27
W15.2
12
W40
12
W35
W35
W35
W35
5
12
8
W17
27
W40
317
Κ.), stimulated in vitro with her HLA-identical male sib
HLA-C
CW3
CW3
CW3
CW3
—
CW3
CW2
—
CW2 CW3
CW1
CW3
—
CW3
CW4
CW4
CW4
CW4
—
CW3
CW2
CW3
Sex
Female
Male
Male
Male
Male
Male
Male
Male
Male
Male
Male
Female
Female
Female
Female
Female
Female
Female
Female
Female
Female
Female
Female
Female
Female
•
%kilT
-
0
44
32
53
43
48
51
- 2
- 2
- 2
- 1
7
17
10
13
10
8
6
- 2
11
8
Ο
1
0
1
" Effector to target ratio = 70:1.
b
 The HLA antigens shared with patient 2 are underlined.
TABLE 3. Killing pattem of patient 1 (Mrs. R.) against her HLA-
identical sibling donor
Time post-trans-
plant (weeks)
Mixed leukocyte
culture Stimulation
index
CML"
Direct Indirect (specificStimulation)
31
42
52
72
74
2.8
1.1
1.6
1.1
1.0
18% kill
67% kill*
60% kül
48% kill
13% kill
3% kill
" In the indirect CML effector cells of patient 1 (Mrs. R) were made
using cells from her HLA-'dentical brother as stimulator rells. In the
direct CML Mrs. R.'s ce)is were tested without in vitro Stimulation
against her HLA-identical brother.
4
 To facilitate the comparison between the percentage of Cr release,
the results are given only of the effector to target ratio, 70:1.
share HLA-A2 have a poorer graft survival than those who do
not share HLA-A2.
DISCUSSION
We have concluded from these data that lymphocytes from
two, possibly three patients suffering from aplastic anaemia,
recognized HLA-A2-positive male target cells. The low level of
killing obtained against some HLA-A2 female target cells sug-
gested that at least one other clone was present that recognized
other HLA-A2-associated gene products. This was not surpris-
ing, since all such patients received many blood transfusions;
20 in the case of patient 2 and more than a 100 in the case of
patient 1. One would have expected that this would have led to
many more reactions directed to non-HLA antigens. The detec-
tion of a predominant specificity was thus a surprising obser-
vation. It was even more surprising to find that 3 of 14 patients
who demonstrated non-HLA killing recognized the same pre-
dominant specificities, namely, HLA-A2 and maleness. Patient
2 suffered from a severe aplastic anaemia and was immunized
by multiple blood transfusions and pregnancies. Patient 1,
however, had received in addition a bone marrow graft from
her HLA-identical brother, which was subsequently rejected.
Thus, it follows that blood transfusions and possibly pregnan-
cies are sufficient in themselves to induce HLA-restricted anti-
H-Y cytotoxicity and that bone marrow transplantation was
not a necessary prerequisite.
Positive cytotoxic tests directed to HLA-identical siblings
have been described before in multi-transfused patients, but
these have not been examined for the HLA restriction phenom-
enon (8, 11, 16). However, it was remarkable that in all three
studies killing was only obtained with patients who carried
HLA-A2. Some indication for preferential killing of a male
sibling's cells by a female patient's cells was indicated in one
case (case 5, Reference (11)). Of the 14 patients studied in our
series (7 male and 4 female patients carrying the HLA-A2
antigen), 3 cases were found showing preferential killing of male
cells by female cells. Several hypotheses are suggested to ex-
plain these findings. They include: (1) The presence of a Ir gene
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Responder Stirnulator Target %Kül
Bone marrow recipient Mrs R (patient HLA-identical male siblmg donor
1)
Bone marrow recipient Mrs R (patient Unrelated SD-identical male donor
1)
Bone marrow recipient Mrs R (patient Unrelated SD-identical male donor
1)
HLA-identical male sibhng donor 13
HLA identical male sibhng donor 68
Unrelated SD-identical male donor 53
HLA phenotypes
Patient 1
Identical sibhng donor
Unrelated male donor
HLA Α
2
2
2
HLA Β
12w40
12w40
12 w40
HLAC
Cw3
Cw3
Cw3
TABLE 5 Külmg pattern of cells of patient 1 (Mrs R ) stimulated in vitro on HLA-A, B, and C-identical but HLA D-different
unrelated individuals"
Targets
HLA Phenotypes
HLA Α HLA Β HLA C
Sex
Patient 1
sib"
1
2
3
4
5
6
10
11
12
13
14
15
16
17
18
19
20
21
22
23
1
2
2_
2_
1
28·
11
3
11
2*
2
2
2
2
11
3
3
29
29
3
9
W31
W31
2_
3
11
3
_2_
3
3
2_
W26
W31
12
12
12
8
5
7
5
7
7
8
W17
5
12.
W35
12
7
W22
8
7
7
8
W15
W40
W40
W40
W40
27
12
12.
12_
8
W15 2
W15 2
W35
W40
W35
W40
W40
W35
W35
W35
12
W40
12.
12
W35
2W17
CW3
CW3
CW3
CW3
CW2
CW5
CW3CW4
CW3
CW4
CW3
CW4
CW3CW4
CW3
CW4
CW4
CW4
CW3
CW4
CW3
Female
Male
Male
Male
Male
Male
Male
Male
Male
Male
Male
Female
Female
Female
Female
Female
Female
Female
Female
Female
Female
Female
Female
Female
Female
-4
68
39
53
46
42
43
70
- 2
-5
7
2
4
10
6
6
0
6
7
7
4
1
- 1
' HLA phenotype of the stimulator cell HLA-A2, B12, Bw40, Cw3
* The HLA antigens shared with patient 1 are underhned
:
 HLA-identical bone marrow donor
TABLE 6 Two-year actuanal cadavenc renal graft survival in
Eurotransplant patients sex and HLA-A2 data for male donors and
female recipients
Leukocyte antibody positive group
Donor A2 positive A2 negative „
Recipient A2 positive A2 negative
η = 48" η = 50
Leukocyte antibody negative group
57 9% 61 0%
1 9 6
η = 53 η = 53
0 24
Ρ
0 05
0 08
* At nsk after 2 years
for H-Y hnked to IILA-A2 (2) Α pecuhar lmmunogenecity of
the A-2-H-Y complex (3) The high frequency of HLA-A2 and
H-Y antigens in blood transfusions
Without further knowledge'of the nature of the effector and
target cells, lt IS at the moment difficult to choose between
these three suggestions The major histocompatibility complex
restnction phenomenon first descnbed in the mouse for virally
coded antigens (17) and later for mmor histocompatibility
antigens (2), includmg H-Y (5), also occurs in man as demon-
strated here by our data and those of others These other
examples mclude the küling of mfluenza-infected target cells
(10) and dmitrochlorobenzene-treated target cells (3) In both
cases there seemed to be an mdication that there was a pref-
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erence for sharing of a specific HLA antigen between killer and
target cells. The low level of killing of some female target cells
in our study indicated that the restriction was not exclusive to
H-Y, but nevertheless HLA-A2 seemed to be the restricting
antigen.
With regard to the immunological memory of this phenom-
enon, it was considered of interest to ask how long such reac-
tions persisted after immunization. If they became undetecta-
ble, was it possible to reinduce the specific killing? In one case
(unpublished data) we were able to detect HLA-restricted H-Y
killing 3 years after the last blood transfusion, suggesting that
memory was very long-lived.
In the above study patient 1 was monitored for over 74 weeks
after the bone marrow transplantation. Although a few blood
transfusions were administered during this period, there was a
progressive decline in the level of killing obtained with her cells.
Despite this it was possible to reinduce high levels of specific
killing by priming in vitro with cells from an HLA-A, -B, and
-C-identical and HLA-D-different, unrelated male individual.
This anamnestic response to the HLA-identical male sibling
was not only found in patient 1 but was also demonstrated in
the other cases. These findings indicated that after primary
sensitization, the development of cytotoxic effector cells is
dependent on the effect of Τ helper cells. These would respond
to the foreign HLA-D determinant on the unrelated A2 male
cells used for in vitro priming. It is possible that our observa-
tions find clarification in the hypothesis of associative recogni-
tion proposed by Lake and Mitchison (9), in which they sug-
gested that immunity against non-major histocompatibility
complex determinants may more readily be evoked in the
presence of major histocompatibility complex alloantigens.
There is some indication that the observations contained in
this study may be of relevance in the context of clinical bone
marrow and kidney transplantation. In this context it is perhaps
relevant to note that bone marrow grafts between HLA-iden-
tical siblings have a significantly poorer graft survival if trans-
plan ted across a sex difference (1, 12, 14). Furthermore, a
retrospective study of cadaveric renal allograft survival at 2
years showed a significant influence of sex difference between
donor and recipient who shared HLA antigens. This only oc-
curred in the antibody-producing group. In previous studies it
has been shown that matching for the HLA-A and -B antigens
influences graft survival, espacially in patients who had formed
leukocyte antibodies. In this group matching for HLA-A and
-B antigens seemed to be more important than in the antibody-
nonproducing group, where other as yet unidentified HLA gene
products seemed to play a role. The fact that the effect of male
incompatibility operated only in the antibody-producing HLA-
A2 group suggested that this group alone could exhibit the
HLA-restricted killing. Nonantibody producers on the other
hand had a better graft survival than antibody producers (13).
Thus, it could be suggested either that this Tätter group was
incapable of exhibiting the restricted killing phenomenon or
simply that higher levels of suppressor cells were generated in
these cases.
One phenomenon remained for which we have no explanation
and that was the failure of patient 2 to generate a positive CML
when sensitized in vitro to her mother's cells (Table 1). Α
similar failure to develop positive CML in instances where one
might expect this to occur across HLA-incompatible situations
was a frequent finding in our studies of patients who had
received blood transfusions.
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